Elagolix is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist primarily used to treat moderate to severe pain associated with endometriosis. As an analytical benchmark, the associated reference… Read more





![Chemical structure of 3-[2(R)-amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F830346-50-4-3-2R-amino-2-phenylethyl-5-2-fluoro-3-methoxyphenyl-1-2-fluoro-6-trifluoromethylbenzyl-6-methylpyrimidine-241H3H-dione.png&w=3840&q=75)






























Elagolix is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist primarily used to treat moderate to severe pain associated with endometriosis. As an analytical benchmark, the associated reference standards, synthetic impurities, and stable isotope labelled compounds are essential for rigorous quality control and pharmaceutical research. These materials allow laboratories to perform accurate impurity profiling, supporting the identification and quantification of process-related substances and degradation products that may arise during manufacturing or storage. By utilizing these high-quality compounds, researchers can conduct precise method validation, stability studies, and routine batch testing in compliance with regulatory standards. Whether for developing new analytical assays or ensuring the consistency of finished drug products, these reference standards provide the necessary support for maintaining the safety, efficacy, and integrity of pharmaceutical development throughout the entire product lifecycle.